![]() Amoy Diagnostics Amoy Diagnostics (AmoyDx, 厦门艾德生物医药科技股份有限公司) is a company that provides molecular diagnostic products and services for oncology precision medicine. | BGI Genomics BGI Genomics (华大基因, 深圳华大基因股份有限公司) is a company offering genomic sequencing and proteomic services. | ![]() Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. | |
Founding Date | Founding Date 2008 | Founding Date 1999 | Founding Date 2012 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Xiamen, CN HQ Singapore, SG | Locations Shenzhen, CN HQ Brisbane, AU Copenhagen, DK Addis Ababa, ET Hong Kong, HK Budapest, HU Kobe, JP see more | Locations Shanghai, CN HQ |
Employees | Employees 1,144 | Employees 3,702 | Employees 2,578 |
Valuation ($) | Valuation ($) 1.3 b | Valuation ($) 2.7 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥1.2b (FY, 2025) | Revenue (est.) ¥3.7b (FY, 2025) | Revenue (est.) ¥2.4b (FY, 2025) |
Cost of goods | Cost of goods ¥208.5m (FY, 2025) | Cost of goods ¥2.3b (FY, 2025) | Cost of goods ¥466.5m (FY, 2025) |
Gross profit | Gross profit ¥976m (FY, 2025) | Gross profit ¥1.4b (FY, 2025) | Gross profit ¥2b (FY, 2025) |
Net income | Net income ¥361.3m (FY, 2025) | Net income (¥637.8m) (FY, 2025) | Net income (¥1b) (FY, 2025) |
BGI Genomics (华大基因, 深圳华大基因股份有限公司) is a company offering genomic sequencing and proteomic services.
View company
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View company